A new FDA-approved device, called a DBS device, claims to use adaptive deep brain stimulation to treat some with Parkinson's disease.

Patent-pending innovation cools high-density data centers with ‘just a sip of water,' half the power of traditional systems ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Comprehensive Market Analysis Highlights Growing Clinical Relevance Across Various Diseases, Limited Clinical Applications in Oncology and Significant Market Potential Attracting New Entrants and ...

Several Rpd3-like HDAC complexes have also been observed in mammals 18,19. Elucidation of their function has been hampered, however, by the much more convoluted and redundant nature of mammalian ...

Biodexa Pharmaceuticals PLC ("Biodexa” or the "Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company ...

HDACs are already known to play a role in cancer, and several HDAC inhibitors have been approved by the U.S. Food and Drug Administration for other cancers other than prostate. The team found that ...

Issued shares, total voting rights, market capitalization As of May 29, 2025, there were 50,506,308,922 ordinary shares, equivalent to 5,050,630 American Depositary Shares (ADSs), outstanding. The ...